Atlanta Consulting Group Advisors, LLC Novo Nordisk A S Transaction History
Atlanta Consulting Group Advisors, LLC
- $403 Billion
- Q3 2024
A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 5,876 shares of NVO stock, worth $513,386. This represents 0.17% of its overall portfolio holdings.
Number of Shares
5,876
Previous 1,839
219.52%
Holding current value
$513,386
Previous $262 Million
166.54%
% of portfolio
0.17%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.76 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.16 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...